×
About 1,970 results

ALLMedicine™ Pediatric Hematology Center

Research & Reviews  905 results

COVID-19 has changed the way we think about training future pediatric hematologists/onc...
https://doi.org/10.1002/pbc.29088
Pediatric Blood & Cancer; Moerdler S, Gampel B et. al.

Apr 29th, 2021 - COVID-19 has upended medical practice and education, but has also catalyzed enhancements in the field. Early on, a local group of researchers united to investigate the impact of the pandemic on pediatric hematology oncology (PHO). From this group,...

Evaluation of Pediatric Hematology Referrals at a Tertiary University Hospital in West ...
https://doi.org/10.1097/MPH.0000000000002159
Journal of Pediatric Hematology/oncology; Bluhm P, Eldem I et. al.

Apr 26th, 2021 - One in 40 pediatric office visits in the United States result in referral to subspecialty care, mostly for secondary opinion. The aim of this study was to evaluate the necessity of pediatric hematology referrals from Eastern New Mexico and West Te...

Feasibility of a Pilot Home Phlebotomy Program for Pediatric Hematology/Oncology Patien...
https://doi.org/10.1097/MPH.0000000000002162
Journal of Pediatric Hematology/oncology; Sisler I, Cohen D et. al.

Apr 22nd, 2021 - Medical care during the Coronavirus 2019 global pandemic required significant shifts in health care delivery systems. Telehealth was widely deployed but was of limited utility for patient populations who rely heavily on laboratory monitoring. This...

American Society of Pediatric Hematology/Oncology (ASPHO) 2021 Paper and Poster Abstracts.
https://doi.org/10.1002/pbc.29060
Pediatric Blood & Cancer;

Apr 21st, 2021 - American Society of Pediatric Hematology/Oncology (ASPHO) 2021 Paper and Poster Abstracts.|2021||

Use of granulocyte transfusion in early period in life-threatening infections of pediat...
https://doi.org/10.1016/j.transci.2021.103134
Transfusion and Apheresis Science : Official Journal of T... Koc BS, Tekkesin F et. al.

Apr 16th, 2021 - Despite all the developments in medicine, infections continue to be one of the most important causes of mortality in pediatric hematology and oncology patients. The more severe the degree of neutropenia develops after intensive chemotherapy in can...

see more →

Guidelines  15 results

Japan society of clinical oncology/Japanese society of medical oncology-led clinical re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046581
International Journal of Clinical Oncology; Naito Y, Mishima S et. al.

Jan 24th, 2020 - The development of novel antitumor agents and accompanying biomarkers has improved survival across several tumor types. Previously, we published provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA...

APHON/ASPHO Policy Statement for the Transition of Patients With Sickle Cell Disease Fr...
https://doi.org/10.1177/1043454215591954
Journal of Pediatric Oncology Nursing : Official Journal ... Bryant R, Porter JS et. al.

Oct 15th, 2015 - With advances in medical care, the majority of children with sickle cell disease are surviving to adulthood. Patients, families, and providers now face the need for this growing population to move from pediatric- to adult-focused care. In order to...

Recommendations for the use of long-term central venous catheter (CVC) in children with...
https://doi.org/10.1007/s00277-015-2481-1
Annals of Hematology; Giordano P, Saracco P et. al.

Aug 24th, 2015 - Central venous catheters (CVC), used for the management of children with hemato-oncological disorders, are burdened by a significant incidence of mechanical, infective, or thrombotic complications. These complications favor an increasing risk in p...

Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014
https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease
NHLBI

Aug 31st, 2014 - These guidelines were developed by an expert panel composed of health care professionals with expertise in family medicine, general internal medicine, adult and pediatric hematology, psychiatry, transfusion medicine, obstetrics and gynecology, eme.

Fertility Preservation for Pediatric and Adolescent Young Adult (AYA) Cancer Patients
http://aphon.org/UPLOADS/Education/pp4.pdf
Lisa Bashore

Jul 31st, 2014 - Pediatric hematology/oncology nurses are an important source of information for patients and families regarding topics important to their quality of life, such as fertility preservation. It is APHON’s position that discussions regarding fertility.

see more →

Clinicaltrials.gov  997 results

COVID-19 has changed the way we think about training future pediatric hematologists/onc...
https://doi.org/10.1002/pbc.29088
Pediatric Blood & Cancer; Moerdler S, Gampel B et. al.

Apr 29th, 2021 - COVID-19 has upended medical practice and education, but has also catalyzed enhancements in the field. Early on, a local group of researchers united to investigate the impact of the pandemic on pediatric hematology oncology (PHO). From this group,...

JAMA Publishes Trial Results Delayed 5 Years. Here's Why
https://www.medscape.com/viewarticle/950245

Apr 29th, 2021 - A treatment for shortening the painful episodes of sickle cell disease (SCD) is not effective, results published in JAMA indicate. But the effort it took to publish the findings is an important part of the story and reveal problems with data owner...

Evaluation of Pediatric Hematology Referrals at a Tertiary University Hospital in West ...
https://doi.org/10.1097/MPH.0000000000002159
Journal of Pediatric Hematology/oncology; Bluhm P, Eldem I et. al.

Apr 26th, 2021 - One in 40 pediatric office visits in the United States result in referral to subspecialty care, mostly for secondary opinion. The aim of this study was to evaluate the necessity of pediatric hematology referrals from Eastern New Mexico and West Te...

Feasibility of a Pilot Home Phlebotomy Program for Pediatric Hematology/Oncology Patien...
https://doi.org/10.1097/MPH.0000000000002162
Journal of Pediatric Hematology/oncology; Sisler I, Cohen D et. al.

Apr 22nd, 2021 - Medical care during the Coronavirus 2019 global pandemic required significant shifts in health care delivery systems. Telehealth was widely deployed but was of limited utility for patient populations who rely heavily on laboratory monitoring. This...

American Society of Pediatric Hematology/Oncology (ASPHO) 2021 Paper and Poster Abstracts.
https://doi.org/10.1002/pbc.29060
Pediatric Blood & Cancer;

Apr 21st, 2021 - American Society of Pediatric Hematology/Oncology (ASPHO) 2021 Paper and Poster Abstracts.|2021||

see more →

News  51 results

JAMA Publishes Trial Results Delayed 5 Years. Here's Why
https://www.medscape.com/viewarticle/950245

Apr 29th, 2021 - A treatment for shortening the painful episodes of sickle cell disease (SCD) is not effective, results published in JAMA indicate. But the effort it took to publish the findings is an important part of the story and reveal problems with data owner...

Choosing Wisely: 5 Recommendations on Testing to Avoid in Pediatric Hematology
https://www.staging.medscape.com/viewarticle/922471

Dec 10th, 2019 - ORLANDO, Florida — There's a new Choosing Wisely list in hematology focused specifically on children, with five tests or procedures that experts advise should be avoided, with some exceptions. The list, which was produced by an expert panel with r...

Choosing Wisely: 5 Recommendations on Testing to Avoid in Pediatric Hematology
https://www.medscape.com/viewarticle/922471

Dec 10th, 2019 - ORLANDO, Florida — There's a new Choosing Wisely list in hematology focused specifically on children, with five tests or procedures that experts advise should be avoided, with some exceptions. The list, which was produced by an expert panel with r...

Think twice: Choosing Wisely recommendations on testing to avoid in pediatric hematology
https://www.mdedge.com/hematology-oncology/article/213955/pediatrics/think-twice-choosing-wisely-recommendations-testing/page/0/1?channel=306

Dec 10th, 2019 - Previous studies on the platelet transfusions in patients with hematologic malignancies have shown that 10,000/mcL is the appropriate threshold, with no difference in bleeding above that number and increased bleeding below it, Dr. Bercovitz said.

Master trial seeks to aid drug development for pediatric AML
https://www.mdedge.com/hematology-oncology/article/200740/aml/master-trial-seeks-aid-drug-development-pediatric-aml?channel=181
Jennifer Smith

May 12th, 2019 - NEW ORLEANS – Researchers are organizing a master trial in an attempt to improve the treatment of pediatric acute myeloid leukemia (AML). The Pediatric Acute Leukemia (PedAL) trial is an effort to collect data on all pediatric AML patients.

see more →

Patient Education  2 results see all →